NHI to cover CAR T-cell therapy for two types of cancer from November

From November, patients with two types of cancers will be eligible to receive CAR T-cell treatment under Taiwan's National Health Insurance (NHI) system, the National Health Insurance Administration (NHIA) said Sunday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)